Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer

Aim. To assess the pharmacoeconomic feasibility of including lenvatinib in the list of vital and essential drugs (VED) and the state program for providing to the necessary drugs to treat patients with differentiated radioiodine-resistant thyroid cancer. Materials and methods. The design of the study...

Full description

Saved in:
Bibliographic Details
Main Authors: S. K. Zyryanov (Author), I. N. Dyakov (Author)
Format: Book
Published: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available